Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions
- 1 March 1994
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 24 (3) , 288-290
- https://doi.org/10.1111/j.1365-2222.1994.tb00233.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of the secretory response of the nasal mucosa to methacholine and histamineJournal of Applied Physiology, 1993
- Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effect on their symptoms, quality of life, and nasal cytologyJournal of Allergy and Clinical Immunology, 1992
- Ipratropium bromide (atrovent nasal spray) reduces the nasal response to methacholineJournal of Allergy and Clinical Immunology, 1992
- Alterations of muscarinic acetylcholine receptors in the nasal mucosa of allergic patients in comparison with nonallergic individualsJournal of Allergy and Clinical Immunology, 1991
- How and why the nose runsJournal of Allergy and Clinical Immunology, 1991
- Anticholinergic Treatment of Watery RhinorrheaAmerican Journal of Rhinology, 1990
- Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromideJournal of Allergy and Clinical Immunology, 1987
- Cold Air-Induced Rhinorrhea and High-Dose IpratropiumJAMA Otolaryngology–Head & Neck Surgery, 1987
- Innervation of human nasal glandsJournal of Neurocytology, 1972